Overview

Dapagliflozin Effect on Erythropoiesis and Physical Fitness

Status:
Unknown status
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
Dapagliflozin effect on erythropoiesis and physical fitness in patients with type 2 diabetes - a randomized, double-blind, controlled, parallel group, exploratory study
Phase:
Phase 4
Details
Lead Sponsor:
GWT-TUD GmbH
Treatments:
Dapagliflozin
Hydrochlorothiazide